Europe Liposome Drug Delivery Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology); Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Country

No. of Pages: 124    |    Report Code: TIPRE00014191    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Liposome Drug Delivery Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Liposome Drug Delivery Market – By product type

1.3.2        Europe Liposome Drug Delivery Market – By Technology

1.3.3        Europe Liposome Drug Delivery Market – By Application

1.3.4        Europe Liposome Drug Delivery Market – By Country

2.           Liposome Drug Delivery Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Liposome Drug Delivery – Market Landscape

4.1         Overview

4.1.1        Europe– PEST Analysis

4.2         Expert Opinion

5.           Europe Liposome Drug Delivery Market – Industry Dynamics

5.1         Market Drivers

5.1.1        Rising prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        Increasing R&D Expenditures in Pharmaceutical Companies

5.2         Market Restraints

5.2.1        High Cost Involved in Development of Drug Delivery Systems

5.3         Market Opportunities

5.3.1        Development of New Lipid Composition for Stability and Optimization of Drugs

5.4         Future Trends

5.4.1        Increasing Popularity of Liposomes in Drug Delivery

5.5         Impact Analysis

6.           Liposome Drug Delivery Market –Asia Pacific Analysis

6.1         Europe Liposome Drug Delivery Market Revenue Forecast And Analysis

7.           Liposome Drug Delivery Market Analysis – By Product

7.1         Overview

7.2         Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

7.3         Liposomal Doxorubicin

7.3.1        Overview

7.3.2        Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Liposomal Paclitaxel

7.4.1        Overview

7.4.2        Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Liposomal Amphotericin B

7.5.1        Overview

7.5.2        Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.           Liposome Drug Delivery Market – By Technology

8.1         Overview

8.2         Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

8.3         Stealth Liposome Technology

8.3.1        Overview

8.3.2        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Non-PEGylated Liposome Technology

8.4.1        Overview

8.4.2        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5         DepoFoam Liposome Technology

8.5.1        Overview

8.5.2        Depo Foam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Lysolipid Thermally Sensitive Liposome (LTSL) Technology

8.6.1        Overview

8.6.2        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.           Liposome Drug Delivery Market – By Application

9.1         Overview

9.2         Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

9.3         Fungal Diseases

9.3.1        Overview

9.3.2        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Cancer Therapy

9.4.1        Overview

9.4.2        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Pain Management

9.5.1        Overview

9.5.2        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6         Viral Vaccine

9.6.1        Overview

9.6.2        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.7         Photodynamic Therapy

9.7.1        Overview

9.7.2        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.        Liposome Drug Delivery Market – Geographic Analysis

10.1      Europe: Liposome Drug Delivery Market

10.1.1     Overview

10.1.2     Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

10.1.3     Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5     Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.6     Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8     UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9     France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.10  Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.11  Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.        Impact Of COVID-19 Pandemic On European Liposome Drug Delivery Market

11.1      Europe: Impact assessment of COVID-19 Pandemic

12.        Liposome Drug Delivery Market –Company Profiles

12.1      Takeda Pharmaceutical Company Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Novartis AG

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Luye Pharma Group

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Johnson & Johnson Services, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Ipsen Pharma

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Gilead Sciences, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Celsion, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Astellas Pharma Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 15.          Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.          Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.          Glossary of Terms, Liposome Drug Delivery Market

LIST OF FIGURES

Figure 1.           Liposome drug delivery Market Segmentation

Figure 2.           Europe Liposome drug delivery Market

Figure 3.           The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market

Figure 4.           Europe PEST Analysis

Figure 5.           Europe Liposome Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027

Figure 6.           Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)

Figure 7.           Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 8.           Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 9.           Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

Figure 12.        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Depo Foam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

Figure 16.        Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

Figure 17.        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Europe: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 25.        Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic In European Country Markets

 

The List of Companies - Europe Liposome Drug Delivery Market

  1. Takeda Pharmaceutical Company Limited
  2. Novartis AG
  3. Luye Pharma Group
  4. Johnson & Johnson Services, Inc
  5. Ipsen Pharma
  6. Gilead Sciences, Inc
  7. Celsion, Inc
  8. Astellas Pharma Inc